News

2024

Press Release
Sysmex Begins Sales of Protein Assay Kits for Regenerative Cellular Medicine
- Automated Quality Control Testing of Cellular Therapeutics -
Press Release
Sysmex’s PA-100 AST System for Rapid Detection of Antimicrobial Susceptibility Wins One of the UK’s Biggest Science Prizes “Longitude Prize on AMR”
Press Release
Regarding an On-Site Inspection by the Japan Fair Trade Commission (PDF:144KB)
Press Release
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 (PDF:291KB)
Press Release
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2024 (PDF:251KB)
Press Release
Notice Regarding the Booking of a Loss on Valuation of Shares of Subsidiaries and Associates and a Provision for Loss on Guarantees (Non-Consolidated Financial Statements) (PDF:71KB)
Press Release
Announcement of Executive Change (PDF:158KB)
Group Company News
Medicaroid Receives MHLW Approval for the Use of the hinotori™ Surgical Robot System in Thoracic Surgery (Medicaroid)
Press Release
Sponsorship of the “Public-Private Partnership Project Invite Hyogo’s Students to EXPO 2025”
- Providing Opportunities for the Future-Leading Generations to Experience Unique Learning “Here” and “Now” - (PDF:309KB)
Information
Sysmex received an Award for Science and Technology (Development Category) in “the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology”
Press Release
Sysmex Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States and EU Countries
Press Release
Soluble Immune Checkpoint Factors in Blood as Potential Biomarkers of Therapeutic Efficacy for ICI Cancer Immunotherapy and Assessing T-cell Exhaustion (PDF:249KB)
Press Release
Sysmex Begins Sales of Six Testing Parameters for the Immunoassay Panel Related to Gynecological and Gonadal Hormones in Japan
- Contributing to the Diagnosis and Treatment of Gynecological Disorders and Infertility Treatment -
Information
Selected as a "Next Nadeshiko: Companies Supporting Dual-career and Co-parenting" in 2023, for creating an attractive workplace where everyone can work comfortably with peace of mind.
Information
Implementing the Group-wide Unified Social Contribution Activity, the “Sysmex Gives Back Campaign”
Press Release
Announcement of Organizational and Personnel Changes (PDF:242KB)
Press Release
Initiated In-house Production of HISCL™ TARC Assay Kit and HISCL™ ANP Assay Kit
- Succession of Manufacturing and Marketing Approval from Shionogi to Accelerate Global Expansion and Business Growth in the Immunochemistry Field -
Information
Educational Initiatives for the Next Generation - Implementing Health Education for Elementary School Students and SDG Education for Junior and Senior High School Students -
Information
【Conference presentation】Presenting the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases
Press Release
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2024 (PDF:179KB)
Press Release
Notice Concerning Share Split and Partial Amendments to the Articles of Incorporation (PDF:232KB)
Information
Sysmex Selected for Inclusion in the Sustainability Yearbook 2024 by S&P Global
Press Release
Sysmex and Hitachi High-Tech Agree to Collaborate on Development of New Genetic Testing Systems
Press Release
Sysmex and CellaVision Expand Alliance with a View to Advancing Hematology Solutions
Press Release
Strengthening the Direct Sales and Service System for Business Expansion in Italy
Information
Sysmex Selected as One of the Global 100's Most Sustainable Companies in the World for the Fifth Time
Information
Sysmex Corporate Introduction Movie Has Been Released